Which prosthesis is more resistant to vascular graft XXXX : @entity736 or Omniflow II biosynthetic grafts?

@entity794 @entity11248 @entity281 @entity35 @entity736
PURPOSE: The aim of this study was to determine whether @entity736 grafts or Omniflow II biosynthetic grafts are more resistant to @entity281 caused by @entity794 . METHODS: Sixty @entity35 were divided into six groups. In Groups 1A, 1B and 1C, a @entity736 graft was implanted in each @entity35 , and, in Groups 2A, 2B and 2C, a biosynthetic graft was implanted in each @entity35 . @entity794 was inoculated into Groups 1B, 1C, 2B and 2C, and the @entity35 in Groups 1C and 2C were treated with @entity11248 . One week later, the @entity35 were euthanized, the grafts were removed and a microbiological count was performed. A histopathological examination was subsequently carried out, and the C-reactive protein, prealbumin and leukocyte levels were investigated. RESULTS: There were no significant differences in the C-reactive protein, prealbumin and leukocyte levels. The differences in the results of the microbiological evaluations between the groups were significant. The quantitative culture results showed no bacterial growth in Groups 1A, 1C and 2A. The number of bacteria in Group 1B was statistically lower than that in Group 2B. When the groups receiving treatment were compared, Group 2C had bacterial growth, whereas Group 1C did not. The histopathological examinations showed similar results. CONCLUSIONS: Omniflow II grafts are more susceptible to @entity281 than @entity736 grafts.
